Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Skacel T"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
von Minckwitz, G., Schwenkglenks, M., Skacel, T., Lyman, G.H., Pousa, A. Lopez, Bacon, P., Easton, V., Aapro, M.S.
Publikováno v:
In European Journal of Cancer 2009 45(4):608-617
Autor:
von Minckwitz, G. *, Kümmel, S., du Bois, A., Eiermann, W., Eidtmann, H., Gerber, B., Hilfrich, J., Huober, J., Costa, S.D., Jackisch, C., Grasshoff, S.-T., Vescia, S., Skacel, T., Loibl, S., Mehta, K.M., Kaufmann, M.
Publikováno v:
In Annals of Oncology February 2008 19(2):292-298
Autor:
Romieu, G., Clemens, M., Mahlberg, R., Fargeot, P., Constenla, M., Schütte, M., Easton, V., Skacel, T., Bacon, P., Brugger, W.
Publikováno v:
In Critical Reviews in Oncology and Hematology 2007 64(1):64-72
Background: Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with multiple myeloma. Ixazomib is ideally suited for maintenance therapy given its convenient once-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7a2acf7f9477bb9d6fa6364f70564f15
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106326
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106326
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
Autor:
Richardson, P.G. (Paul G.), San-Miguel, J.F. (Jesús F.), Moreau, P. (Philippe), Hajek, R. (R.), Dimopoulos, M.A. (Meletios A.), Laubach, J.P. (Jacob P.), Palumbo, A. (Antonio), Luptakova, K. (Katarina), Cessario, R. (Romanus), Romanus, D. (Dorothy), Skacel, T. (Tomas), Kumar, S. (Shaji), Anderson, K. (Kenneth C.)
Substantial improvements in survival have been seen in multiple myeloma (MM) over recent years, associated with the introduction and widespread use of multiple novel agents and regimens, as well as the emerging treatment paradigm of continuous or lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::52a4dcb98d2db5335c87d550be0ac01a
https://hdl.handle.net/10171/64746
https://hdl.handle.net/10171/64746
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
Substantial improvements in survival have been seen in multiple myeloma (MM) over recent years, associated with the introduction and widespread use of multiple novel agents and regimens, as well as the emerging treatment paradigm of continuous or lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::05494730a9b6ccb7942d08fd2075c984
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106888
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106888
Autor:
von Minckwitz, G., Kümmel, S., du Bois, A., Eiermann, W., Eidtmann, H., Gerber, B., Hilfrich, J., Huober, J., Costa, S. D., Jackisch, C., Grasshoff, S.-T, Vescia, S., Skacel, T., Loibl, S., Mehta, K. M., Kaufmann, M.
Background: TAC (docetaxel/doxorubicin/cyclophosphamide) is associated with high incidences of grade 4 neutropenia and febrile neutropenia (FN). This analysis compared the efficacies of four regimens for primary prophylaxis of FN and related toxic ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______805::a9467c2a458bca6c7339ed4848193abd
http://doc.rero.ch/record/300252/files/mdm438.pdf
http://doc.rero.ch/record/300252/files/mdm438.pdf
Autor:
Mattioli, R., Gridelli, C., Castellanos, J., Duque, A., Alfredo Falcone, Mansutti, M., Bacon, P., Lawrinson, S., Skacel, T., Casas, A.
Publikováno v:
Università di Pisa-IRIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::934614a42d04b2819c517a4468787d40
http://hdl.handle.net/11568/134305
http://hdl.handle.net/11568/134305
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.